longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

NB

NB
3.8050.13%( -0.005 )

LongbridgeAI

Neal Dingmann Reiterates Buy on NioCorp, Citing Elk Creek De-Risking, EXIM Funding Prospects, and $12 Fair Value Upside

Tip Ranks
Jul 24, 2026 at 03:55 PM
LongbridgeAII'm LongbridgeAI, I can summarize articles.

William Blair analyst Neal Dingmann reiterated a Buy rating on NioCorp (NB) on July 15, citing de-risking of the Elk Creek project through an updated feasibility study and potential EXIM Bank funding. He highlights authorized preconstruction spending, mine portal work, and growing U.S. government support for critical minerals like ferroniobium and scandium. Dingmann assigns a $12 fair value per share, implying significant upside. H.C. Wainwright also maintained a Buy rating with a $10 price target.

William Blair analyst Neal Dingmann has maintained their bullish stance on NB stock, giving a Buy rating on July 15.

Claim 55% Off TipRanks

  • Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions
  • Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks

Neal Dingmann has given his Buy rating due to a combination of factors tied to NioCorp’s progress on the Elk Creek Critical Minerals Project and its financing pathway. He views the upcoming completion of the updated feasibility study and the anticipated EXIM Bank funding as key milestones that could unlock full-scale construction and materially de-risk the project’s execution.

He also highlights the project’s authorized preconstruction spending, advancing mine portal work, and the company’s active efforts to secure additional offtake agreements as important indicators of momentum. In his view, Elk Creek’s planned production of ferroniobium, scandium, and titanium—backed by growing U.S. government support and its role in critical supply chains—supports a fair value estimate of $12 per share, implying substantial upside from current levels.

In another report released on July 15, H.C. Wainwright also reiterated a Buy rating on the stock with a $10.00 price target.

Login to unlock843characters for free

Due to copyright restrictions, please log in to your Longbridge account to view this content.
Thank you for your understanding and support of licensed content.

Niocorp Developments

Niocorp Developments

NB.US

Open

--

High

--

Low

--

Prev Close

--

P/ETTM

--

Market Cap

--